Upper GI 2017

Neoscope Study – Tumor Regression (Primary Endpoint)

OxCapRT (n=42)

CarPacRT (n=43)

n 5

%

n

%

11.9* 31.0 31.0

12 16 10

27.9* 37.2 23.3

1 (pCR)

13 13

2 3 4 5

4 0 1 6

9.5 0.0 2.4

3 0 0 2

7.0 0.0 0.0 4.7

Missing TRG data

14.3

No surgery

* 13.9% and 29.3% respectively of those undergoing surgery

10 of first 38 patients in the CarPacRT arm attained pCR, thereby meeting pre-specified criteria of success

Mukherjee S et al. ASCO-GI 2016

© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick